RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Laboratory Corporation of America Holdings Stock

Laboratory Corporation of America Holdings ROE 2024

Laboratory Corporation of America Holdings ROE

0.05

Ticker

LH

ISIN

US50540R4092

WKN

895308

In 2024, Laboratory Corporation of America Holdings's return on equity (ROE) was 0.05, a -58.1% increase from the 0.13 ROE in the previous year.

Laboratory Corporation of America Holdings Aktienanalyse

What does Laboratory Corporation of America Holdings do?

The Laboratory Corporation of America Holdings, also known as LabCorp, is an American company that has been operating in the medical diagnostics industry since 1978. It was founded by a doctor and a laboratory scientist with the goal of simplifying and improving the diagnostic process. LabCorp is now the largest independent diagnostic company in the world, with over 60,000 employees. LabCorp's business model is to contribute to the prevention, diagnosis, and treatment of diseases through its comprehensive diagnostic services. The company offers a wide range of medical laboratory tests, clinical studies, and DNA analysis services. LabCorp operates more than 2,000 locations in the United States, Canada, and Europe, and provides its services worldwide. LabCorp is divided into three business segments: Diagnostics, Drug Development, and CRO (contract research organization). Under the Diagnostics segment, the company offers laboratory tests for clinical detection, cancer diagnosis, genetic testing, and more. The company specializes in blood, body fluid, and tissue analyses and also offers a variety of specialized tests to answer specific medical questions. LabCorp's Drug Development segment aims to accelerate and improve drug development through its comprehensive clinical studies. The company assists with study coordination and compliance with regulatory requirements to ensure accurate and reliable study results. LabCorp's CRO segment offers clinical study services, including study planning, design, execution, and analysis. This enables the company to develop groundbreaking treatment options for diseases that do not yet have adequate therapies. LabCorp is also heavily involved in the development of personalized diagnostics to provide patients with even more accurate diagnosis and treatment options. LabCorp offers a wide range of products. The company is a leading provider of clinical laboratory services and offers a broad range of laboratory tests for infections, hormonal disorders, autoimmune diseases, allergies, and cancer. Some of the specialized tests offered by LabCorp include genetic testing for cancer diagnosis and inherited metabolic disorders. In the Drug Development segment, the company offers a wide range of clinical studies aimed at developing new drugs and therapies. LabCorp also utilizes its DNA identification services to confirm the identity of individuals or assist in forensic cases. In summary, LabCorp is a successful company specialized in medical diagnostics. Over the past 40 years, the company has experienced impressive growth and positioned itself as a leading provider of clinical laboratory services. With its wide range of diagnostic services, clinical studies, and DNA identification services, LabCorp provides innovative solutions for the medical challenges of the future. Laboratory Corporation of America Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Laboratory Corporation of America Holdings's Return on Equity (ROE)

Laboratory Corporation of America Holdings's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Laboratory Corporation of America Holdings's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Laboratory Corporation of America Holdings's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Laboratory Corporation of America Holdings’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Laboratory Corporation of America Holdings stock

What is the ROE (Return on Equity) of Laboratory Corporation of America Holdings this year?

The ROE of Laboratory Corporation of America Holdings this year is 0.05 undefined.

How has the Return on Equity (ROE) of Laboratory Corporation of America Holdings developed compared to the previous year?

The ROE of Laboratory Corporation of America Holdings has increased by -58.1% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Laboratory Corporation of America Holdings?

A high ROE indicates that Laboratory Corporation of America Holdings generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Laboratory Corporation of America Holdings?

A low ROE can indicate that Laboratory Corporation of America Holdings is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Laboratory Corporation of America Holdings affect the company?

A change in ROE (Return on Equity) of Laboratory Corporation of America Holdings can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Laboratory Corporation of America Holdings?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Laboratory Corporation of America Holdings?

Some factors that can influence Laboratory Corporation of America Holdings's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Laboratory Corporation of America Holdings pay?

Over the past 12 months, Laboratory Corporation of America Holdings paid a dividend of 2.88 USD . This corresponds to a dividend yield of about 1.29 %. For the coming 12 months, Laboratory Corporation of America Holdings is expected to pay a dividend of 3.19 USD.

What is the dividend yield of Laboratory Corporation of America Holdings?

The current dividend yield of Laboratory Corporation of America Holdings is 1.29 %.

When does Laboratory Corporation of America Holdings pay dividends?

Laboratory Corporation of America Holdings pays a quarterly dividend. This is distributed in the months of March, June, June, September.

How secure is the dividend of Laboratory Corporation of America Holdings?

Laboratory Corporation of America Holdings paid dividends every year for the past 7 years.

What is the dividend of Laboratory Corporation of America Holdings?

For the upcoming 12 months, dividends amounting to 3.19 USD are expected. This corresponds to a dividend yield of 1.43 %.

In which sector is Laboratory Corporation of America Holdings located?

Laboratory Corporation of America Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Laboratory Corporation of America Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Laboratory Corporation of America Holdings from 9/13/2024 amounting to 0.72 USD, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.

When did Laboratory Corporation of America Holdings pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Laboratory Corporation of America Holdings in the year 2023?

In the year 2023, Laboratory Corporation of America Holdings distributed 2.16 USD as dividends.

In which currency does Laboratory Corporation of America Holdings pay out the dividend?

The dividends of Laboratory Corporation of America Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Laboratory Corporation of America Holdings

Our stock analysis for Laboratory Corporation of America Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratory Corporation of America Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.